Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
Patents for C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids (5,704)
05/2003
05/22/2003WO2003042176A1 Azabicyclo compound, matrix metalloprotease inhibitor, and skin preparation
05/22/2003WO2002044144A3 Nucleophilic approach for preparing radiolabeled imaging agents and associated compounds
05/22/2003CA2466344A1 Azabicyclic-phenyl-fused-heterocyclic compounds and their use as alpha7 nachr ligands
05/21/2003EP1311505A2 Quinuclidine-substituted heteroaryl moieties for treatment of disease ( nicotinic acetylcholine receptor ligands )
05/21/2003CN1109023C Preparation of pyrimiding derivatives
05/20/2003US6566509 Compound for use as bactericide
05/20/2003US6566362 Use as topical antibiotics
05/15/2003WO2003040147A1 Azabicyclic-substituted-heteroaryl compounds for the treatment of disease__________________________________________________________________________________________________________________________
05/15/2003WO2003040096A2 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003US20030092642 Diphosphate salt of a 4" -substituted-9-deoxo-9A-AZA-9A-homoerythromycin derivative and its pharmaceutical composition
05/15/2003CA2466375A1 Azabicyclic-substituted-heteroaryl compounds for the treatment of disease
05/15/2003CA2466284A1 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/14/2003EP1309589A2 Urea compounds and methods of uses
05/14/2003CN1108302C Process for resolving (R,S(Z))-alpha-(methoximino)-alpha-(1-azabicyclo (2,2,2) oct-3-yl) acetonitrile
05/13/2003US6562967 Drug screening; purity
05/13/2003US6562966 Combining a racemic or a diastereomeric mixture of a chiral substrate with a nucleophile, in the presence of a chiral non-racemic catalyst
05/13/2003US6562335 NK-1 receptor antagonists for prevention of neurogenic inflammation in gene therapy
05/13/2003CA2115443C Azabicyclo arylacetylene and arylenyne oximes as cholinergic agents and methods of treatment
05/08/2003WO2003037896A1 N-azabicyclo-substituted hetero-bicyclic carboxamides as nachr agonists
05/08/2003US20030087931 Nitrogen heteroaromatic ring connected with the same or another aromatic ring through a triazine distribution agent; anticancer agents
05/08/2003CA2464194A1 N-azabicyclo-substituted hetero-bicyclic carboxamides as nachr agonists
05/07/2003CN1416423A 2,4,Di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineoplastic agents
05/07/2003CN1107505C Synergistic combination of AIDS antiviral compounds and HIV inhibitor
05/02/2003EP1305304A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor
05/02/2003EP1305270A1 Kinetic resolutions of chiral 2- and 3-substituted carboxylic acids
05/02/2003EP1037886B1 Triazine angiogenesis inhibitors
05/02/2003EP0786988B1 Use of nk1 receptor antagonists for preparing cardio-regulatory drugs
04/2003
04/24/2003WO2003033495A1 Quinuclidine derivatives, processes for preparing them and their uses as m2 and/or m3 muscarinic receptor inhibitors
04/24/2003WO2003033480A1 Lactam derivatives as antagonists for human 11cby receptors
04/24/2003WO2003033476A1 Pyrimidinones as melanin concentrating hormone receptor 1
04/24/2003WO2003033472A1 Quinoline or quinazoline derivatives inhibiting auto- phosphorylation of fibroblast growth factor receptors
04/24/2003WO2002085848A3 Synthesis of pancratistatin prodrugs
04/24/2003US20030078263 Nonnucleotide compounds which interact with specific structures of dna; anticancer agents
04/24/2003CA2463509A1 Lactam derivatives as antagonists for human 11cby receptors
04/24/2003CA2463508A1 Pyrimidinones as melanin concentrating hormone receptor 1
04/24/2003CA2462980A1 Quinuclidine derivatives, processes for preparing them and their uses as m2 and/or m3 muscarinic receptor inhibitors
04/23/2003EP1303492A2 Aza-bridged-bicyclic amino acid derivatives as alpha 4 integrin antagonists
04/22/2003CA2239187C Inhibitors of farnesyl protein transferase
04/17/2003US20030073707 Quinuclidine-substituted hetero-bicyclic aromatic compounds for the treatment of disease
04/15/2003US6548499 Substituted quinoxaline derivatives as interleukin-8 receptor antagonists
04/10/2003WO2003029252A1 Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
04/10/2003WO2003004493A8 Novel compounds, their preparation and use
04/10/2003US20030069284 Anticancer agent
04/09/2003EP1300407A1 Carbamates derived from arylalkylamines
04/09/2003EP0674623B1 Bicyclic fibrinogen antagonists
04/08/2003CA2062271C Derivatives of substituted imidazol-2-one and process for their preparation
04/03/2003WO2002102766A3 Combretastatin a-3 prodrug
04/02/2003EP0587800B1 Immunomodulatory azaspiranes
04/02/2003CN1407970A Urea compounds having muscarinic receptor antagonist activity
04/02/2003CN1104431C Resolution of [R,S]-2-(methoxyimido)-2-(1-azebicyclic [2,2,2] octa-3-radical) acetonitrile
03/2003
03/27/2003WO2003024949A1 Dna-pk inhibitors
03/27/2003WO2003024926A2 Methods and compositions of novel triazine compounds
03/27/2003CA2461074A1 Methods and compositions of novel triazine compounds
03/27/2003CA2454023A1 Dna-pk inhibitors in the treatment of retroviral mediated diseases
03/26/2003EP1200431B1 Quinuclidine derivatives and their use as muscarinic m3 receptors ligands
03/26/2003EP0763026B1 Gastrin and cck antagonists
03/20/2003WO2003022790A2 Biphenylene compounds
03/20/2003US20030055250 Pteridine compounds for the treatment of psoriasis
03/20/2003US20030055080 Quinuclidine derivatives and their use as muscarinic M3 receptor ligands
03/20/2003US20030055049 For therapy of abnormal cell growth, such as cancer, in mammals
03/20/2003US20030055043 Substituted azabicyclic moieties for the treatment of disease
03/20/2003US20030053966 Insoluble organic UV screening agents of aryl vinylene ketone type, and cosmetic use thereof
03/19/2003EP1012131B1 Enantioselective reduction of ketones with a silane agent/metal compound/chiral ligand system
03/19/2003CN1404482A Pteridine compounds for the treatment of psoriasis
03/18/2003CA2141048C Substituted benzylamino nitrogen containing non-aromatic heterocycles
03/13/2003WO2003020029A1 Arylamines as inhibitors of chemokine binding to us28
03/12/2003EP1289929A1 Shortened synthesis of 3,3-diarylpropylamine derivatives
03/12/2003CN1402729A Polycycloalkylpurines as adenosine receptor antagonists
03/06/2003WO2003018549A2 Bicyclic compounds as inhibitors of chemokine binding to us28
03/06/2003US20030045557 Thiadiazoles and oxadiazoles and their use as phosphodiesterase-7 inhibitors
03/06/2003US20030045528 Antibacterial and antiprotozoal agents
03/06/2003US20030045523 Nicotinic cholinergic receptor antagonists
03/05/2003EP1287011A1 Hygromycin a derivatives for the treatment of bacterial and protozoal infections
03/05/2003EP1286967A1 Cyclohexane derivatives and their use as therapeutic agents
03/05/2003EP0801067B1 Novel quinuclidine derivatives and medicinal composition thereof
03/05/2003CN1400973A Novel biarylcarboxamides
03/04/2003US6528526 Inhibition of cell proliferation and/or cell matrix production and/or cell movement (chemotaxis) and/or T cell activation and proliferation
03/04/2003US6528524 Treating the multiple drug resistance, arrhythmia, spasms and malaria; reacting hydrochloric acid with cinchonine or to cinchonine monohydrochloride in form cinchonine dihydrochloride; high purity
02/2003
02/27/2003WO2003015517A1 Agonists and antagonists of 5h3-like receptors of invertebrate s as pesticides
02/27/2003US20030040513 P2x7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular diseases
02/27/2003CA2456290A1 Agonists and antagonists of 5h3-like receptors of invertebrate s as pesticides
02/26/2003EP1284975A1 Ammonium compounds bearing an electrophilic fluorine, reagent containing same, method using same and synthesis method for obtaining them
02/25/2003US6525065 Pharmaceutical compositions and methods for effecting dopamine release
02/25/2003US6525059 Substituted pyrazoles as p38 kinase inhibitors
02/20/2003WO2003013531A1 Phenyl derivatives as factor xa inhibitors
02/20/2003WO2003013528A1 Substituted pyridin-4-ones and their use as gonadotropin-releasing hormone receptor antagonists.
02/20/2003WO2002100858A3 Quinuclidine-substituted heteroaromatic compounds as ligands at nicotinic acetylcholine receptors
02/20/2003CA2455871A1 Substituted pyridin-4-ones and their use as gonadotropin-releasing hormone receptor antagonists.
02/13/2003WO2003011799A1 Kinetic resolutions of chirat 3- and 3-substituted carboxylic acids
02/13/2003WO2002096855A3 Anticholinergic compounds and methods of use
02/13/2003CA2456166A1 Kinetic resolutions of chiral 2- and 3-substituted carboxylic acids
02/12/2003EP1282620A1 Azabicyclic carbamates and their use as alpha-7 nicotinic acetylcholine receptor agonists
02/06/2003WO2003009848A1 Use of nk-1 receptor antagonists to modify unwanted behavior in dogs, cats and horses
02/06/2003US20030028018 Treating diseases characterized by activity of vascular endothelial growth factor receptor tyrosine kinases such as cancer
02/06/2003US20030027822 Sodium channel modulators
02/06/2003US20030026850 Penetration of blood, brain barrier; transdermal drug delivery; mixing with dinitroamide compound
02/06/2003CA2448722A1 Use of nk-1 receptor antagonists to modify unwanted behavior in dogs, cats and horses
02/05/2003EP1281391A1 Organic insoluble UV filters of the aryl vinylene ketone type and their use in cosmetics
02/05/2003CN1395467A Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents
02/05/2003CN1394855A Substituted heterocyclic compound
1 ... 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 ... 58